Philippe Colombat

9.4k total citations · 2 hit papers
118 papers, 6.3k citations indexed

About

Philippe Colombat is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Philippe Colombat has authored 118 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pathology and Forensic Medicine, 34 papers in Oncology and 30 papers in Genetics. Recurrent topics in Philippe Colombat's work include Lymphoma Diagnosis and Treatment (49 papers), Chronic Lymphocytic Leukemia Research (21 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Philippe Colombat is often cited by papers focused on Lymphoma Diagnosis and Treatment (49 papers), Chronic Lymphocytic Leukemia Research (21 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Philippe Colombat collaborates with scholars based in France, Canada and Belgium. Philippe Colombat's co-authors include Guillaume Cartron, Hervé Watier, P. Bardos, Gilles Salles, Philippe Solal‐Céligny, Laurent Dacheux, Nicolas Gillet, Evelyne Fouquereau, Nöel Milpied and Vincent Delwail and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Philippe Colombat

114 papers receiving 6.1k citations

Hit Papers

Therapeutic activity of humanized anti-CD20 monoclona... 1987 2026 2000 2013 2002 1987 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Colombat France 33 2.8k 2.4k 1.6k 1.5k 1.4k 118 6.3k
John A. Lust United States 68 1.5k 0.5× 7.1k 3.0× 3.6k 2.3× 1.5k 1.0× 730 0.5× 257 18.7k
Andreas Engert Germany 30 2.3k 0.8× 1.8k 0.8× 901 0.6× 997 0.7× 721 0.5× 179 3.9k
William C. Wood United States 59 2.0k 0.7× 8.4k 3.5× 224 0.1× 897 0.6× 1.1k 0.8× 211 15.0k
Françesc Solé Spain 39 1.5k 0.5× 1.4k 0.6× 1.9k 1.2× 460 0.3× 172 0.1× 241 5.5k
John P. Leonard United States 67 9.4k 3.3× 6.7k 2.8× 5.2k 3.4× 3.1k 2.1× 3.1k 2.2× 490 17.1k
Moshe Maor United States 56 802 0.3× 3.5k 1.5× 3.4k 2.2× 157 0.1× 1.6k 1.1× 204 13.9k
John Radford United Kingdom 65 8.8k 3.1× 7.8k 3.3× 3.0k 1.9× 1.8k 1.2× 2.2k 1.6× 377 15.7k
Jürgen Wolf Germany 37 1.3k 0.5× 2.7k 1.1× 392 0.3× 732 0.5× 617 0.4× 139 5.4k
David I. Marks United Kingdom 47 871 0.3× 2.6k 1.1× 1.5k 0.9× 1.6k 1.1× 108 0.1× 162 9.8k
Young Kim United States 37 324 0.1× 787 0.3× 213 0.1× 227 0.2× 220 0.2× 264 5.5k

Countries citing papers authored by Philippe Colombat

Since Specialization
Citations

This map shows the geographic impact of Philippe Colombat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Colombat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Colombat more than expected).

Fields of papers citing papers by Philippe Colombat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Colombat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Colombat. The network helps show where Philippe Colombat may publish in the future.

Co-authorship network of co-authors of Philippe Colombat

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Colombat. A scholar is included among the top collaborators of Philippe Colombat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Colombat. Philippe Colombat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Morin, Alexandre J. S., et al.. (2023). Predictors and outcomes of nursing students' engagement trajectories at the beginning of their program. Journal of Vocational Behavior. 145. 103917–103917. 5 indexed citations
3.
Ferreira-Maldent, Nicole, Marjan Ertault, Martine Delain, et al.. (2018). Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report. Journal of Medical Case Reports. 12(1). 199–199. 5 indexed citations
6.
Blouin, Pascale, Flavie Arbion, Anne Pagnier, et al.. (2010). Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA‐AraC. Pediatric Blood & Cancer. 55(4). 757–760. 8 indexed citations
7.
Damaj, Gandhi, Marc Bernard, Steven Le Gouill, et al.. (2008). Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features. Blood. 112(11). 2603–2603. 3 indexed citations
8.
Gallay, Nathalie, Adriana López, Philippe Colombat, et al.. (2007). The Role of Platelet/Endothelial Cell Adhesion Molecule–1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells. Cancer Research. 67(18). 8624–8632. 29 indexed citations
9.
Milpied, Nöel, T. Lamy, Philippe Casassus, et al.. (2004). Front-Line High-Dose Chemotherapy (HDT) Combined with Rituximab for Adults with Aggressive Large B-Cell Lymphoma (DLBCL) : Goelams 074 Trial.. Blood. 104(11). 902–902. 2 indexed citations
10.
Cartron, Guillaume, Olivier Hérault, Lotfi Benboubker, et al.. (2002). Quantitative and Qualitative Analysis of the Human Primitive Progenitor Cell Compartment after Autologous Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 11(2). 359–368. 7 indexed citations
11.
Domenech, Jorge, Olivier Hérault, Lotfi Benboubker, et al.. (2002). Decreased Stroma Adhesion Capacity of CD34 + Progenitor Cells from Mobilized Peripheral Blood Is Not Lineage- or Stage-Specific and Is Associated with Low β 1 and β 2 Integrin Expression. Journal of Hematotherapy & Stem Cell Research. 11(3). 491–500. 15 indexed citations
12.
Deconinck, Éric, T. Lamy, C. Foussard, et al.. (2000). Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial. British Journal of Haematology. 109(4). 736–742. 41 indexed citations
13.
Limat, Samuel, Marie-Christine Woronoff-Lemsi, Nöel Milpied, et al.. (2000). Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy. European Journal of Cancer. 36(18). 2360–2367. 19 indexed citations
15.
André, Marc, M. Henry‐Amar, Didier Blaise, et al.. (1998). Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.. Blood. 92(6). 1933–40. 103 indexed citations
16.
Colombat, Philippe, D Donadio, L Fouillard, et al.. (1994). Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.. PubMed. 13(2). 157–62. 64 indexed citations
17.
Delain, Martine, Claude Linassier, Philippe Goupille, et al.. (1994). VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.. Journal of Clinical Oncology. 12(12). 2706–2713. 4 indexed citations
18.
Fignon, A, F Fétissof, Gauthier Calais, et al.. (1993). [Small cell carcinoma of the ovary. A clinical and anatomo-pathologic entity].. PubMed. 22(4). 372–8. 7 indexed citations
19.
Colombat, Philippe, F Fétissof, G. Calais, et al.. (1990). [Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy].. PubMed. 77(8). 811–20. 1 indexed citations
20.
Colombat, Philippe, Norbert Claude Gorin, C Binet, et al.. (1990). The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.. Journal of Clinical Oncology. 8(4). 630–637. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026